Review decision date: February 2014

Review decision: 

Following consultation with stakeholders this guideline has now been placed on the static list.

Next review date: TBC

This clinical guideline offers evidence-based advice on the care and treatment of children and young people under the age of 19 having sedation for therapeutic or diagnostic procedures.

This guideline was previously called sedation in children and young people: Sedation for diagnostic and therapeutic procedures in children and young people.

October 2014

The footnotes about the licensing of drugs for sedation in children and young people have been amended to say that at the time of publication (December 2010), no drugs have a UK marketing authorisation specifically for sedation in all ages of infants, children and young people under 19, and to emphasise that prescribers should follow current summaries of product characteristics and seek advice if needed. In addition, appendix D has been deleted.

Your responsibility

The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.

Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.

  • National Institute for Health and Care Excellence (NICE) accreditation logo